These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 9336462
1. Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA. Kahlen JP, Carlberg C. Nucleic Acids Res; 1997 Nov 01; 25(21):4307-13. PubMed ID: 9336462 [Abstract] [Full Text] [Related]
2. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs. Quack M, Carlberg C. Mol Pharmacol; 1999 Jun 01; 55(6):1077-87. PubMed ID: 10347251 [Abstract] [Full Text] [Related]
3. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions. Herdick M, Steinmeyer A, Carlberg C. Chem Biol; 2000 Nov 01; 7(11):885-94. PubMed ID: 11094341 [Abstract] [Full Text] [Related]
4. Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation. Schräder M, Nayeri S, Kahlen JP, Müller KM, Carlberg C. Mol Cell Biol; 1995 Mar 01; 15(3):1154-61. PubMed ID: 7862109 [Abstract] [Full Text] [Related]
5. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK. Bone; 1995 Aug 01; 17(2 Suppl):33S-38S. PubMed ID: 8579895 [Abstract] [Full Text] [Related]
6. Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions. Thompson PD, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR. J Biol Chem; 1998 Apr 03; 273(14):8483-91. PubMed ID: 9525962 [Abstract] [Full Text] [Related]
7. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M, Freedman LP, Li H, Christakos S. Mol Endocrinol; 1998 Sep 03; 12(9):1367-79. PubMed ID: 9731705 [Abstract] [Full Text] [Related]
8. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor. Thompson PD, Hsieh JC, Whitfield GK, Haussler CA, Jurutka PW, Galligan MA, Tillman JB, Spindler SR, Haussler MR. J Cell Biochem; 1999 Dec 01; 75(3):462-80. PubMed ID: 10536369 [Abstract] [Full Text] [Related]
9. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors. Fernandez-Martin JL, Kurian S, Farmer P, Nanes MS. Mol Cell Endocrinol; 1998 Jun 25; 141(1-2):65-72. PubMed ID: 9723887 [Abstract] [Full Text] [Related]
10. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast. Kephart DD, Walfish PG, DeLuca H, Butt TR. Mol Endocrinol; 1996 Apr 25; 10(4):408-19. PubMed ID: 8721985 [Abstract] [Full Text] [Related]
11. The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors. Carlberg C, Mathiasen IS, Saurat JH, Binderup L. J Steroid Biochem Mol Biol; 1994 Nov 25; 51(3-4):137-42. PubMed ID: 7981122 [Abstract] [Full Text] [Related]
12. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements. Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, Vandewalle M, Carlberg C, Bouillon R. J Bone Miner Res; 2001 Apr 25; 16(4):625-38. PubMed ID: 11315990 [Abstract] [Full Text] [Related]
13. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts. Thompson PD, Remus LS, Hsieh JC, Jurutka PW, Whitfield GK, Galligan MA, Encinas Dominguez C, Haussler CA, Haussler MR. J Mol Endocrinol; 2001 Oct 25; 27(2):211-27. PubMed ID: 11564604 [Abstract] [Full Text] [Related]
14. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation. Kimmel-Jehan C, Jehan F, DeLuca HF. Arch Biochem Biophys; 1997 May 01; 341(1):75-80. PubMed ID: 9143355 [Abstract] [Full Text] [Related]
15. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators. Herdick M, Carlberg C. J Mol Biol; 2000 Dec 15; 304(5):793-801. PubMed ID: 11124027 [Abstract] [Full Text] [Related]
16. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo. Lemon BD, Freedman LP. Mol Cell Biol; 1996 Mar 15; 16(3):1006-16. PubMed ID: 8622645 [Abstract] [Full Text] [Related]
17. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Bettoun DJ, Burris TP, Houck KA, Buck DW, Stayrook KR, Khalifa B, Lu J, Chin WW, Nagpal S. Mol Endocrinol; 2003 Nov 15; 17(11):2320-8. PubMed ID: 12893883 [Abstract] [Full Text] [Related]
18. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements. Kimmel-Jehan C, Darwish HM, Strugnell SA, Jehan F, Wiefling B, DeLuca HF. J Cell Biochem; 1999 Aug 01; 74(2):220-8. PubMed ID: 10404392 [Abstract] [Full Text] [Related]
20. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Staal A, van Wijnen AJ, Birkenhäger JC, Pols HA, Prahl J, DeLuca H, Gaub MP, Lian JB, Stein GS, van Leeuwen JP, Stein JL. Mol Endocrinol; 1996 Nov 01; 10(11):1444-56. PubMed ID: 8923469 [Abstract] [Full Text] [Related] Page: [Next] [New Search]